510(k) device
Vocalis and Vocalis Sm
Cytophil, Inc. · System, Vocal Cord Medialization (MIX, Class II) · First FDA decision Jan 5, 2009, newest Jan 5, 2009Head and neck cancer
Last checked: Nov 21, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
2
Naming "Vocalis"
MAUDE reports
0
Brand "Vocalis", since 2015
PubMed studies
422
Mentioning "Vocalis"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Vocalis and Vocalis Sm
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- VOCALIS AND VOCALIS SM510(k)
K081816 · Decided Jan 5, 2009 · 193 days after receipt
Device type: System, Vocal Cord Medialization (MIX) · Otolaryngology (ENT)
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Vocalis", any status and sponsor, newest update first.
University Hospital, Strasbourg, FranceAcademic, hospital or other
NCT00213863 · 10 participants (planned) · Start Dec 2010 · Primary completion May 2016
Device: Vocal fold medialization (thyroplasty) prosthesis by insertion of a new implant allowing very easy and quick setting · For: Vocal Cord Paralysis
Sites: Strasbourg, France
1 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Vocalis", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code MIX
34 reports: 6 malfunction, 28 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Vocalis"[tiab]. The summary above synthesizes these.
- Sulcus Vocalis.
Soni RS, Dailey SH · Otolaryngol Clin North Am · 2019Review
- Sulcus vocalis. An update.
Martins RHG, Pierri IG, Loli A, et al. · Am J Otolaryngol · 2024Review
- Office-Based Laryngology.
Lamm SA, Buckmire RA, Shah RN · Otolaryngol Clin North Am · 2025Review
- Bilateral sulcus vocalis.
Eller R, Hawkshaw M, Sataloff RT · Ear Nose Throat J · 2006Case Reports
- Sulcus vocalis: a review.
Giovanni A, Chanteret C, Lagier A · Eur Arch Otorhinolaryngol · 2007Review
- Sulcus vocalis: functional aspects.
Hirano M, Yoshida T, Tanaka S, et al. · Ann Otol Rhinol Laryngol · 1990
- Sulcus Vocalis: Results of Excision Without Reconstruction.
Andreadis K, Hoffman K, D'Angelo D, et al. · Laryngoscope · 2020Evaluation Study, Research Support, N.I.H., Extramural
- Sulcus Vocalis and Benign Vocal Cord Lesions: Is There Any Relationship?
Saraniti C, Patti G, Verro B · Int J Environ Res Public Health · 2023
- Sulcus vocalis.
Sataloff JB, Defatta RA, Hawkshaw MJ, et al. · Ear Nose Throat J · 2012Case Reports
Other devices of this type
Also filed under product code MIX.
- Silk Voice (SMI-04)Sofregen Medical · 510(k) 2024
- Renu GelCytophil, Inc. · 510(k) 2015
- Calcium Hydroxylapatite Vocal Fold ImplantCytophil, Inc. · 510(k) 2013
- Vf LiquigelCoapt Systems, Inc. · 510(k) 2009
- Vocalis GelCytophil, Inc. · 510(k) 2009
- Modification to Vf Gel PlusCoapt Systems, Inc. · 510(k) 2008
- Vf Gel PlusCoapt Systems, Inc. · 510(k) 2008
- Radiesse Laryngeal ImplantBioform Medical, Inc. · 510(k) 2007
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.